Topoisomerase 2 alpha: a real predictor of anthracycline efficacy? - Wikidata - awgldk - TriplyDB

Topoisomerase 2 alpha: a real predictor of anthracycline efficacy?

Topoisomerase 2 alpha: a real predictor of anthracycline efficacy?

http://www.wikidata.org/entity/Q37989074

about

A phase II study of weekly irinotecan in patients with locally advanced or metastatic HER2- negative breast cancer and increased copy numbers of the topoisomerase 1 (TOP1) gene: a study protocol.In silico discovery of mitosis regulation networks associated with early distant metastases in estrogen receptor positive breast cancers.Quantum dot-based immunofluorescent imaging and quantitative detection of TOP2A and prognostic value in triple-negative breast cancer.Precision treatment for cancer: role of prognostic and predictive markers.Topoisomerase expression and amplification in solid tumours: Analysis of 24,262 patients Synthesis and antitumor mechanisms of a copper(II) complex of anthracene-9-imidazoline hydrazone (9-AIH).TOP2A amplification in breast cancer is a predictive marker of anthracycline-based neoadjuvant chemotherapy efficacy.Role of Topoisomerases in Pediatric High Grade Osteosarcomas: TOP2A Gene Is One of the Unique Molecular Biomarkers of Chemoresponse.Dual-colour CISH is a reliable alternative to FISH for assessment of topoisomerase 2-alpha amplification in breast carcinomas.Phase I and pharmacokinetic study of the novel anthracycline derivative 5-imino-13-deoxydoxorubicin (GPX-150) in patients with advanced solid tumors.The prognostic significance of topoisomerase II alpha protein in early stage luminal breast cancer.

P2860

Q35125726-4A5F1E6E-A315-4C89-962A-6992A86F5BCC Q36629870-7DD5D61D-BD13-444D-B600-719634024D34 Q37376754-51042004-68B9-49C8-A5EF-3A4833FBE052 Q38179024-F7CBF43C-D1B8-4564-9FC1-A9F6D4033E92 Q38669870-196F7E0A-928B-4A0E-B072-10E62DA611E2 Q38883280-A29D8E0E-FA14-4816-97EB-5F609E3DD129 Q39574212-A45591E8-43EB-448E-B363-858F503C723D Q43065457-4550F800-974F-47C2-96C4-D0CA85D53BD7 Q44358325-B881A34C-B1C4-4CC9-9516-3E987AE438F6 Q46770269-A8A6E5C2-9F54-4886-8809-4652904A04CB Q52627272-51456CEC-1757-492A-97EE-F7FBD2BA4B3F

P2860

Topoisomerase 2 alpha: a real predictor of anthracycline efficacy?

http://www.wikidata.org/entity/Q37989074

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Topoisomerase 2 alpha: a real predictor of anthracycline efficacy?

@en

Topoisomerase 2 alpha: a real predictor of anthracycline efficacy?

@nl

type

label

Topoisomerase 2 alpha: a real predictor of anthracycline efficacy?

@en

Topoisomerase 2 alpha: a real predictor of anthracycline efficacy?

@nl

prefLabel

Topoisomerase 2 alpha: a real predictor of anthracycline efficacy?

@en

Topoisomerase 2 alpha: a real predictor of anthracycline efficacy?

@nl

P1433

Q37989074-1D692C87-2D73-4661-B8A7-BDAD29F83D75

P1476

Q37989074-842F0889-CBEA-4C27-8558-B1DFFA3A1F53

P2093

Q37989074-BA4A3896-B59F-4054-94B8-B1204AEF4027

P2860

Q37989074-01FAC669-776F-4FF2-A8F1-40B623C466BA

Q37989074-07354F4F-BE71-401D-93D9-65318FB1F114

Q37989074-0C9A8917-6B7F-4B91-86AA-7EC0F2F6CE53

Q37989074-1501BA95-FB58-42C4-8070-4659FBA65584

Q37989074-1826F64D-D1E5-4AB4-903D-38DC0A754458

Q37989074-18EB0C80-893B-499F-A231-C967DBA3CB32

Q37989074-199C754F-306D-4C03-863F-9BB5AB38F060

Q37989074-1C997402-8555-4EB1-8CB4-1D43CC314133

Q37989074-2EAE1842-3E04-42E4-B026-A015703FD2B4

Q37989074-314F6947-8EC9-47FB-AC1A-D85AA22E18E2

P2888

Q37989074-0BBA86E9-2364-4EBC-98CA-9C58CF0A2A6E

P304

Q37989074-2D0929C4-73F2-4A2C-90C0-EBCD4D404BDB

P31

Q37989074-3673F5F0-C354-4D71-B4BC-B94CAC358A95

P356

Q37989074-A2196CDD-2175-4DE1-AB87-3A4F763224DC

P433

Q37989074-F6FC0300-68F5-4910-B3E0-EFE52965805C

P478

Q37989074-90C93068-EDB5-4EEC-87CD-A69EF2421EE0

P50

Q37989074-BFA03200-7DDA-4054-9512-4002DBA46E06

Q37989074-E71841F5-E7CB-4EB2-9143-01A4A7E54C05

Q37989074-E80DF940-18B4-4DB1-96FE-3945460FE216

P577

Q37989074-1B101FFA-6467-4F15-B8BD-F9BC36E8A12A

P698

Q37989074-D4689724-8EF5-43B6-B019-83FC2D64F69F

P356

S12094-012-0779-1

P1433

Clinical and Translational Oncology

P1476

Topoisomerase 2 alpha: a real predictor of anthracycline efficacy?

@en

P2093

Trinidad Caldés

http://www.w3.org/2001/XMLSchema#string

P2860

Cellular roles of dna topoisomerases: a molecular perspective

Construction, characterization, and complementation of a conditional-lethal DNA topoisomerase IIalpha mutant human cell line

c-erbB2 and topoisomerase IIalpha protein expression independently predict poor survival in primary human breast cancer: a retrospective study

Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials

Anthracyclines: molecular advances and pharmacologic developments in antitumor activity and cardiotoxicity

Supervised risk predictor of breast cancer based on intrinsic subtypes

Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer

HER2 and TOP2A as predictive markers for anthracycline-containing chemotherapy regimens as adjuvant treatment of breast cancer: a meta-analysis of individual patient data.

Dynamics of human DNA topoisomerases IIalpha and IIbeta in living cells

Topoisomerase II is a structural component of mitotic chromosome scaffolds.

P2888

s12094-012-0779-1

P304

163-168

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S12094-012-0779-1

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

14

http://www.w3.org/2001/XMLSchema#string

P50

Eduardo Díaz-Rubio

P577

2012-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22374418

http://www.w3.org/2001/XMLSchema#string